To assess the effects of genetic predisposition of essential hypertension on early renal function in recent insulin-dependent diabetics, we studied inulin.para-aminohippuric, sodium, and lithium clearances in 69 unselected diabetics with (n=20) and without (n=49) a family history of essential hypertension. Despite similar metabolic control, glomerular filtration rate and mean arterial pressure were significantly higher in diabetics with than in those without a family history of hypertension. However, no difference was found between the two groups regarding renal vascular resistance, sodium excretion, or fractional proximal and distal sodium reabsorption. Renal responses to acute captopril (75 mg) administration were evaluated in 27 patients (six with family history of hypertension). Captopril decreased filtration fraction and mean arterial pressure similarly in both groups, whereas glomerular filtration rate and renal vascular resistance decreased more dramatically in diabetics with family history of hypertension. These findings indirectly suggest an abnormal response to angiotensin of vascular tone in recent diabetics with familial predisposition to hypertension. Kenal response to acute nlcardlplne (2.5 mg i.v.) administration was analyzed in 24 patients (five with family history of hypertension). In both groups, nicardipine similarly decreased mean arterial pressure and renal vascular resistance and induced a marked natri lire tic effect due to a predominant reduction in proximal reabsorption of sodium. However, the increase in sodium excretion was twofold to threefold more pronounced in diabetics with a family history of hypertension. Whether these early renal abnormalities may contribute to the risk of diabetic nephropathy, as suggested by retrospective studies, remains to be determined. 1 -2 Hypertension in IDD patients develops mainly in connection with the clinical emergence of nephropathy, whereas those in whom nephropathy does not develop remain normotensive despite the longer duration of diabetes and advancing age. Why some but not all IDD patients are susceptible to diabetic nephropathy has not been determined. Besides poor grycemic control, renal hemodynamic changes and hypertension may play an important role.
D
iabetic nephropathy is the most serious complication of insulinKlependent diabetes (IDD), responsible for a 10-fold excess of cardiovascular mortality due to end-stage renal failure and hypertension. It develops in 30-40% of IDD patients; the risk peaks during the second decade of diabetes and declines thereafter.
1 -2 Hypertension in IDD patients develops mainly in connection with the clinical emergence of nephropathy, whereas those in whom nephropathy does not develop remain normotensive despite the longer duration of diabetes and advancing age. 3 Why some but not all IDD patients are susceptible to diabetic nephropathy has not been determined. Besides poor grycemic control, renal hemodynamic changes and hypertension may play an important role. 4 -6 Of note, an elevation of blood pressure has been observed before any sign of impairment of renal function, and the presence of genetic hypertension accelerates nephropathy in streptozotocin diabetic rats. 6 -7 Inherited predisposition to hypertension was proposed to increase the susceptibility to nephropathy in IDD since nondiabetic parents of IDD patients with nephropathy have higher blood pressure than the parents of IDD patients without nephropathy, 8 -10 and sodium-lithium countertransport (Na + -li + CT) is increased in patients with IDD before the onset of nephropathy and is associated with hyperfiltration. 11 Similarly, nondiabetic subjects genetically predisposed to hypertension were found to have higher velocity of erythrocyte Na + -Li + CT than normotensive controls without familial history of hypertension, and it has been suggested that these abnormalities in red blood cell Na + -Li + CT may be a marker of enhanced renal proximal tubular reabsorption in essential hypertension. 12 -16 Since genetic predisposition to essential hypertension may be a factor predisposing to diabetic nephropathy, possibly through inherited deregulation of membrane ion transport or vascular tone as in essential hypertension, 17 -25 we evaluated in the present study whether a familial history (FH) of hypertension could influence renal hemodynamics, sodium excretion, and tubular handling in the very early stage of diabetes. The response of renal hemoby guest on May 3, 2017 http://hyper.ahajournals.org/ Downloaded from dynamics and renal sodium handling to acute calcium channel blockade and acute converting enzyme inhibition was further assessed using acute nicardipine and captopril administration, respectively.
Methods
Sixty-nine Caucasian patients (44 men), aged 28 ±1 years, participated in this study after informed consent was obtained. All patients were type I diabetics in whom diagnosis was established according to the World Health Organization criteria. 26 These patients were part of an ongoing study of the determinants of early diabetic glomerular hyperfiltration and constituted a homogeneous group, with a mean diabetes duration of 42 days (range, 7-180 days) and short-term insulin therapy of 9±1 days. None of these diabetics had hypertension or diabetic nephropathy. Other main characteristics of these patients are indicated in Table 1 .
First degree relatives were invited to have fasting plasma glucose determination and blood pressure measurement by their practitioner. When blood pressure measurements were not available in all relatives or data were insufficient, patients were not considered for the study. Diabetic patients were divided into two groups according to the presence (FH+, n=20) or the absence ( F H -, n=49) of FH of essential hypertension. FH+ was defined as patients having nonobese and nondiabetic first degree relatives under 60 years of age with diastolic blood pressure greater than 95 mm Hg, mean arterial pressure greater than 117 mm Hg, or receiving antihypertensive treatment. Most relatives were considered hypertensive because they had been receiving antihypertensive therapy.
All patients were investigated in the metabolic ward while on a controlled sodium diet of 90-120 mmol/24 hr. None of the subjects was taking drugs other than insulin. Subjects were studied after correction of hypergh/cemia by conventional insulin therapy, blood glucose levels were below 9 mmol/1 (6±0.5 mmol/1), as estimated by the mean of six consecutive determinations during each clearance procedure. Since /rara-aminohippuric (PAH) clearance may be underestimated due to glucose-PAH addict formation 27 or lithium clearance overestimated in relation to osmotic diuresis, 28 the absence of ketone and glucose was carefully verified in all urine samples for each patient.
The evening before the clearance studies, each participant was given 750 mg lithium carbonate orally to obtain throughout the clearance procedure relatively stable lithium concentrations ranging from 0.20 to 0.25 mmol/1. Clearances were performed in the morning, after overnight fasting, as previously described 29 using a constant rate infusion of inulin (poh/fructosan, Inutest, Laevosan, linz, Austria) and PAH (Nephrotest, Biologische Arbeitsgemeinschaft GmbH, Lien, FRG) during six consecutive clearance periods of 30 minutes each. Urine was collected every 30 minutes by spontaneous voiding, and blood specimens were drawn at the beginning and the end of each collection period. At the end of period 3, sublingual administration of 75 mg captopril was given as a single dose to 27 patients (six FH+, 21 F H -) and intravenous nicardipine (2.5 mg) was infused to 24 patients (five FH+, 19 F H -) . Mean arterial pressure (MAP) was measured using a noninvasive Concentrations of serum angiotensin converting enzyme (ACE) activity were determined before and 60 minutes after captopril administration. After collection, blood samples were ultracentrifuged and serum was kept frozen at -80°C until assayed using an enzymatic kinetic method modified 32 from the method of Cushman and Cheung. Normal values in our laboratory are 21.5±5.4 nmol/min/ml (mean±2 SD).
Calculations and Statistics
Clearances were calculated according to standard clearance formula C=UV/P where U is urine concentration of the substance, V is urine flow, and P is its plasma concentration, and were adjusted for a body surface of 1.73 m 2 . The average of three 30-minute clearance determinations of inulin or PAH was calculated to evaluate glomerular filtration rate (GFR) and effective renal plasma flow (ERPF), respectively. MAP was calculated as the average of all 10-minute measurements during clearance procedure. Renal vascular resistance (RVR) was calculated as RVR=MAPx(l-Ht)/ERPF and filtration fraction (FF) as FF=GFR/ERPF Segmental tubular sodium handling was determined using lithium clearance as an index of absolute proximal escape. 33 Fractional proximal reabsorption of lithium (FPR U ) was calculated as
where C u is clearance of lithium, and fractional distal reabsorption of sodium ( F D R N . ) was calculated as
where CN, is clearance of sodium. Other values were calculated as follows: absolute proximal isoosmotic reabsorption (APR)
where P Nl is the plasma sodium concentration; and fractional excretion of sodium (FE Nl ) FE Na =CWGFR All results were expressed as mean±SEM unless otherwise stated. Statistical analysis was performed using a multivariate model of analysis of variance to compare values in FH+ and F H -groups (SYSTAT statistical software, SYSTAT Inc., Evanston, IU.) and using analysis of variance for repeated measurements to compare the effects of either captopril or nicardipine in the two subgroups of patients according to familial history of hypertension. 34 Differences were considered as significant at the 0.05 level.
Results
The IDD patients studied here had a short duration of diabetes and insulin therapy and had achieved relatively good metabolic control. Average blood glucose was 6 ±0.3 mmol/1, glycated hemoglobin (HbAi c ) 11.7±0.5%, and no patients were glycosuric or ketonuric. Baseline GFR and ERPF for the whole group were 136±2 and 715±18 ml/min • 1.73 m 2 , respectively; these results are similar to our control values and are likely related to the relatively good glycemic control after a few days of insulin treatment (Table 1) .
There was no difference between groups with respect to age, sex ratio, diabetes duration, glycated hemoglobin, plasma glucose, or insulin duration at the start of this study ( In the 27 patients given a single dose of captopril (75 mg), serum ACE activity decreased dramatically (from 27.3±7.4 to 3.1+2.4 nmol/min/ml; p<0.001) indicating nearly complete inhibition of angiotensin II formation in the serum and presumably within the kidney as well. In both FH+ and F H -patients, captopril induced a significant decrease in FF (p<0.001), MAP (/><0.05), and RVR (/?<0.01), whereas ERPF was unchanged (Table 3 and Figure 1 ). GFR decreased only in F Hdiabetics from 140±5 to 127±5 ml/min • 1.73 m 2 (p<0.05). MAP and RVR decreased significantly in both groups, although the decrease in RVR was significantly more pronounced in FH+ than in F H -patients (interaction FHxcaptopril;p<0.05). Captopril induced no natriuretic effect, as indicated by unchanged U Nl • V and FE Nl , despite a slight but significant decrease in FPRu and APR (/><0.01). ADR*,, and FDR N , were unchanged by captopril.
In the 24 patients given acute low dose of nicardipine (2.5 mg), acute calcium channel blockade significantly decreased FF (p<0.05) in F H -group and MAP (p<0.001) and RVR (/?<0.01) in both groups, whereas GFR decreased and ERPF increased nonsignificantly and similarly in FH+ and FH-groups (Table 4 and Figure 2 ). Nicardipine induced in both groups a significant natriuretic effect, probably related to a decrease in FPRu (p<0.001) and APR N . (p<0.05) and, to a lesser extent, in FDR Nl . U N .
• V and FE N , tended to increase more markedly in F H -diabetics (40%, FH+ versus 16%, F H -; and 42%, FH+ versus 12%, F H -, respectively), but the interaction groups x treatment was not significant. Results are expressed as percent changes before and after captopril. FH-, without family history of hypertension; FH+, with family history of hypertension; GFR, glomerular filtration rate; ERPF, effective renal plasma flow; FF, filtration fraction; MAP, mean arterial pressure; RVR, renal vascular resistance; FE Na , fractional sodium excretion; U Nl • V, urinary sodium excretion; FPRL,, fractional proximal reabsorption of lithium; APR, absolute proximal isoosmotic reabsorption; FDRN,, fractional distal sodium reabsorption rate; ADR Nl , absolute distal sodium reabsorption rate.
Discussion
•p<0.05, + p<0.01, tp<0.001 before vs. after captopril. §/?<0.05 interaction captoprilxFH. tant role. 4 -6 Of note, blood pressure was found to increase before any sign of diabetic nephropathy, 6 and the presence of genetic hypertension accelerates nephropathy in streptozotocin diabetic rats. 7 It has been suggested that inherited predisposition to hypertension may increase susceptibility to nephropathy in IDD 14 However, in IDD as well as in essential hypertensive patients, the links between these abnormalities have not been definitely settled.
RVR
In this homogeneous group of recent IDD patients receiving a normal sodium diet and with relatively good metabolic control, we found a slightly albeit significantly higher GFR and MAP in FH+ diabetic patients. Although differences in MAP were slight, it should be noted that blood pressure values represented the average of repeated 10-minute measurements with an automatic device, therefore probably minimizing bias due to "white coat" or to investigator. Higher GFR and MAP have been similarly reported in nondiabetic offspring of essential hypertensive parents. 18^35 In contrast, renal plasma flow and FF were not significantly different in FH+ and in F H -diabetics as reported in some 20 -23 but not all 18 ' 35 studies in nondiabetic offspring of essential hypertensive parents. In our diabetic patients, both absolute and fractional excretion of sodium and lithium were unaffected by a familial history of essential hypertension, whereas APR was slightly but nonsignificantly increased in FH+ IDD patients. Contrasting with an initial report, 14 recent studies using standardized protocols of lithium clearance measurement (controlled sodium diet, supine position) have indicated that with either normal or high sodium diet, the normotensive nondiabetic offspring of hypertensive parents have normal or even decreased proximal tubular reabsorption of sodium.
35
- 36 However, with high sodium supplementation, blood pressure tended to be slightly higher in FH+ patients, whereas sodium excretion and sodium proximal escape were unchanged 35 or increased. 36 There may be several explanations for the lack of difference in renal sodium handling in FH+ or F H -IDD patients. First, some of the discrepancies may be related to sample bias since certain studies enrolled a small number of selected subjects. Second, the diabetic state per se may be confounding because of persistent mild hyperglycemia and ensuing volume expansion 37 due to osmotic shift of glucose and to increased proximal sodium reabsorption, 38 probably through stimulation of sodium-glucose cotransport. 39 Indeed, FPRu and presumably of sodium was significantly increased when compared with our normal control values. 4041 These results raised the question of the validity of the measurement of the erythrocyte Na + -Ii + CT as a marker of Na + -H + antiporter activity in epithelia and particularly the renal tubule. In the proximal tubule, the Na + -H + antiporter has been found to account only for approximately 40% of the active transport of sodium. 42 Moreover, the relation between erythrocyte Na + -Li + CT and epithelial Na + -H + antiporter has been questioned because the Na + -H + exchange in the human and rabbit proximal renal brush border is amiloride sensitive, whereas in both species Na + -Li + CT could not be inhibited by amiloride under a variety of conditions. 43 Insulin resistance and hyperinsulinism are common features in essential hypertension 44 and have been shown to increase renal sodium reabsorption and vascular reactivity through stimulation of certain membrane ion transport systems, particularly the Na + -K + -ATPase and the Na + -H + exchange systems.
45
- 46 In diabetics, high systemic hyperinsulinism and ensuing stimulation of ion transport systems may partially offset the influence of genetic polymorphism of proximal sodium reabsorption, Na + -H + exchange, or both.
A subgroup of essential hypertensive patients with normal or elevated plasma renin activity fail to appropriately increase renal blood flow with increased dietary sodium or conversely to appropriately decrease renal blood flow in response to angiotensin II infusion while on high sodium diet, whereas this abnormal renal response was reversible after short-term converting enzyme inhibition. 21 Of note, recent evidence has been produced that a large fraction (greater than 80%) of these patients, termed "non-modulators," are FH+. 24 -25 Furthermore, a familial aggregation of non-modulation was evidenced, and renal and adrenal features characteristic of non-modulation were found in normotensive subjects with non-modulating hypertensive first degree relatives.
24
- 25 These results suggest that non-modulation may be an inheritable trait and that abnormalities of the control of renal vascular tone may precede essential hypertension.
In the present study, acute administration of captopril induced a significant decrease in FF, MAP, and RVR and an increase in ERPF in both FH+ and F Hgroups of diabetics. Although some difference in the response between groups could have been missed because of the small number of FH+ patients, the decrease in RVR was higher in FH+ than in F Hpatients with IDD, and RVR in FH+ patients with IDD decreased after captopril to levels similar to baseline RVR in F H -patients with IDD. Similar findings have been reported in normotensive FH+ subjects in comparison with F H -normotensive subjects. 20 This suggests that renal vascular tone in subjects genetically predisposed to hypertension is partly dependent on excessive renal angiotensin II formation. In diabetics, this abnormality of renal angiotensin may be blunted due to increased plasma volume and exchangeable sodium. 37 After captopril, GFR decreased slightly but significantly in FH-, whereas it was unchanged in FH+. A similar decrease in GFR was found in healthy FHnormotensive subjects. 40 Contrasting with reports in essential hypertensive and normotensive subjects, 40 -47 captopril did not induce a natriuretic effect in IDD patients, irrespective of a familial history of hypertension, despite a slight but significant decrease in FPR N , and APR N ,. The natriuretic effect of captopril is prominently related to reduced proximal reabsorption, and in IDD patients the angiotensin II-dependent component of sodium proximal reabsorption and its suppression by ACE inhibitor may be blunted by enhanced sodiumglucose cotransport.
Calcium channel blockers have been reported to induce marked renal vasodilation predominantly in the afferent arteriolar resistance. 48 - 49 In our study and as in nondiabetic normotensive subjects, 41 an acute low dose by guest on May 3, 2017 http://hyper.ahajournals.org/ Downloaded from of nicardipine induced a significant decrease in MAP, RVR, and to a lesser extent in FF in both F H -and FH+ groups of diabetics, whereas GFR and ERPF were practically unchanged. In normotensive subjects, the administration of either diltiazem or nifedipine, at doses that do not decrease blood pressure, induced a higher increase in renal blood flow and presumably a larger decrease in RVR in normotensive FH+ subjects.
22
- 23 Since these results have not been observed with nonspecific vasodilators such as nitroprusside or acetylcholine, these observations have been interpreted as evidence for a primary defect in calcium-dependent control of the renovascular smooth muscle. 23 However, since the diltiazem-induced increase in renal blood flow was demonstrated only in sodium-restricted diet, it has been speculated that the enhanced effects of diltiazem on renal blood flow may primarily be due to suppression of the angiotensin II-mediated component of renal vascular tone. 22 In both FH+ and F H -patients with IDD, nicardipine nonsignificantly increased renal plasma flow, whereas it decreased markedly RVR and blood pressure to a similar extent in both groups. The lack of change in ERPF in our experiment may be merely related to the profound decrease in arterial pressure after nicardipine, which due to counterregulating mechanisms, may offset the increase in ERPF as previously found in animals. 50 Calcium channel blockers consistently exert a potent natriuretic effect in animals and normotensive and hypertensive humans 51 -52 even when GFR and renal plasma flow are prevented from increasing either by an aortic clamp 53 or after intrarenal infusion of a low dose of the drug. 54 This natriuretic effect was shown to be related to a decrease in both proximal and distal tubular reabsorption of sodium, probably by directly interfering with sodium transport along the renal tubule. 55 In diabetics, nicardipine induced a similar marked natriuretic effect, essentially due to a decrease in proximal reabsorption of sodium. Of note, changes in sodium excretion were even more pronounced (twofold to threefold higher) in FH+ than in F H -IDD patients.
In conclusion, recent patients with IDD, offspring of nondiabetic essential hypertensive parents, exhibit a pattern of renal abnormalities including an increase in GFR and MAP, whereas RVR and sodium excretion were nonsignificantly increased and decreased, respectively. In accordance with recent reports in normotensive offspring of essential hypertensive parents, fractional proximal reabsorption calculated using lithium clearance was not altered in FH+ diabetics, although values in the whole group were higher than in nondiabetic controls. Acute calcium channel blockade or ACE inhibition induced rather similar responses in FH+ and F H -groups. Since the changes in GFR and blood pressure were quantitatively minor, it remains to be determined whether these renal abnormalities may influence the late renal outcome in diabetics as suggested by retrospective studies.
